WuXi AppTec Co., Ltd. (2359.HK) Stock Competitors & Peer Comparison
See (2359.HK) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Diagnostics & Research Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| 2359.HK | HK$153.00 | -5.56% | 440.3B | 19.49 | HK$7.85 | +1.43% |
| 2268.HK | HK$53.30 | -10.12% | 67.4B | 42.71 | HK$1.25 | N/A |
| 6127.HK | HK$23.76 | -7.98% | 32.5B | 31.32 | HK$0.76 | +0.58% |
| 9860.HK | HK$3.92 | +4.53% | 2.8B | 89.44 | HK$0.04 | N/A |
| 2251.HK | HK$10.30 | -2.09% | 1B | -5.60 | -HK$1.84 | N/A |
| 8037.HK | HK$0.65 | -8.45% | 634.2M | -3.18 | -HK$0.20 | N/A |
| 2325.HK | HK$0.63 | +0.00% | 368.8M | -1.36 | -HK$0.46 | N/A |
| 8247.HK | HK$2.99 | +5.65% | 192.2M | -7.29 | -HK$0.41 | N/A |
| 0928.HK | HK$0.07 | -2.99% | 120.3M | 8.39 | HK$0.01 | N/A |
Stock Comparison
2359.HK vs 2268.HK Comparison July 2026
2359.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2359.HK stands at 440.3B. In comparison, 2268.HK has a market cap of 67.4B. Regarding current trading prices, 2359.HK is priced at HK$153.00, while 2268.HK trades at HK$53.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2359.HK currently has a P/E ratio of 19.49, whereas 2268.HK's P/E ratio is 42.71. In terms of profitability, 2359.HK's ROE is +0.27%, compared to 2268.HK's ROE of +0.16%. Regarding short-term risk, 2359.HK is less volatile compared to 2268.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2359.HK.Check 2268.HK's competition here